Relmada Therapeutics Inc.

0.27
-0.01 (-2.14%)
At close: Apr 04, 2025, 10:11 AM

Relmada Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for RLMD stock have an median target of 1, with a low estimate of 1 and a high estimate of 2. The median target predicts an increase of 270.37% from the current stock price of 0.27.

Target Low Average Median High
Price $1 $1.33 $1 $2
Change 270.37% 392.59% 270.37% 640.74%

Latest Analyst Insight Report

According to 4 stock analyst, the rating for Relmada Therapeutics Inc. is "Hold". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.

Rating Jun 24Sep 24Dec 24
Strong Buy 010
Buy 000
Hold 002
Sell 100
Strong Sell 000
Total 1 1 2

Financial Forecast this Year

Revenue This Year
2.46M
from 0
Increased by -%
Revenue Next Year
10M
from 2.46M
Increased by 306.7%
EPS This Year
-0.95
from 0
Increased by -%
EPS Next Year
-0.8
from -0.95
Increased by 15.8%